[Role of plasma lipoproteins in the function of steroidogenic tissues]

Steroidogenic cells (adrenal, gonads and placenta) utilize cholesterol as a substrate for hormonal biosynthesis. Cholesterol can be synthetized de novo acetate or can enter the cell as a component of plasma lipoproteins, particularly LDL (low density lipoprotein) and HDL (high density lipoprotein). Steroidogenic cells utilize predominantly lipoproteins. Lipoprotein-cholesterol enters the cell by a specific pathway: binding of lipoproteins, particularly LDL to a membrane specific receptor and internalization of the complex receptor-lipoprotein, followed by dissociation of the complex; the receptor is reutilized, while LDL is hydrolyzed by lysosomal enzymes in amino-acids and free cholesterol. The liberated cholesterol is available for utilization by the cell. In addition, lipoproteins modulate intra-cellular cholesterol metabolism via two enzymatic activities; inhibition of hydroxymethyl-glutaryl coenzyme A reductase activity (HMG CoA reductase) which controls the rate limiting step of cholesterol biosynthesis, and stimulation of acyl CoA cholesterol acyltransferase (ACAT) activity which controls the esterification of cholesterol, before its translocation to lipids droplets. Peptide hormones LH/hCG and ACTH regulate lipoproteins metabolism in their target tissues by increasing LDL receptors number, a way which allow more cholesterol to enter the cell. The role of lipoproteins on steroidogenesis has been studied predominantly in adrenal and to a lesser extent in ovary and placenta and poorly in testis. Using a model of cultured porcine Leydig cells, we have demonstrated that de novo synthesis of cholesterol accounts for only 25% of the maximal steroidogenic capacity of these cells. Moreover the effects of lipoprotein LDL was synergistic with that of gonadotropins.